[1]
Abdirasulova, Z.A., Jabbar, B.H., Ismael, S.H., Hussein, A.M., Saleh, S. and Nazir, N.K. 2026. The Usage and Limitations of Gene Therapy Versus Stem Cell Therapy for Myotonic Dystrophy Type 1 (DM1): Special Focus on Immune Response. Trends in Immunotherapy. 10, 1 (Jan. 2026), 189–203. DOI:https://doi.org/10.54963/ti.v10i1.1105.